Key considerations for higher IV dosages include: Severe vitamin B12 deficiency with neurological symptoms
NinjAthlete Performance Optimization PlatformScience-backed biohacking, peptide therapy protocols, HYROX training, and performance optimization
In September 2023 the FDA placed BPC-157 in Category 2 of its 503A interim bulk-substances policy, citing immunogenicity and peptide-characterization concerns, effectively excluding it from the 503A compounding bulk-substances list
State Key Laboratory of Genetic Resources and Evolution, Key Laboratory of Healthy Aging Research of Yunnan Province, Kunming Key Laboratory of Healthy Aging Study, Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming 650201, China 2
Methylcobalamin is often recognized as the most bioavailable source of Vitamin B12